Brief: Amniotics BOD Recommends Shareholders To Accept Offer From Magle Chemoswed

Amniotics AB (publ)

22/03/2024 07:36

March 22 (Reuters) - Amniotics AB (publ)  AMNI.ST :
    * BOARD OF DIRECTORS HAS DECIDED TO RECOMMEND SHAREHOLDERS
OF
AMNIOTICS TO ACCEPT OFFER
    * ACCEPTANCE PERIOD FOR OFFER IS EXPECTED TO COMMENCE ON OR
ABOUT
8 APRIL 2024 AND EXPIRE ON OR ABOUT 29 APRIL 2024
    * MAGLE CHEMOSWED HAS RESERVED RIGHT TO WAIVE CONDITIONS,
INCLUDING, COMPLETING OFFER AT A LOWER LEVEL OF ACCEPTANCE

Source text for Eikon:  ID:nMFN1jNxKv 
Further company coverage:  AMNI.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))